NYSE ARCA | ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index.
The index seeks to track the performance of the common stock ofU. S. exchange-listed biotechnology companies with at least one drug therapy approved by theU. S.
Food and Drug Administration (FDA) for marketing.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals Inc | Healthcare | Biotechnology | 2.39% |
| SAGE | Sage Therapeutic | Healthcare | Biotechnology | 2.34% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 2.30% |
| ADMA | ADMA Biologics Inc | Healthcare | Biotechnology | 2.30% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 2.24% |
| TARS | Tarsus Pharmaceuticals Inc | Healthcare | Biotechnology | 2.23% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 2.21% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 2.18% |
| IMCR | Immunocore Holdings Ltd | Healthcare | Biotechnology | 2.13% |
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 2.09% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 2.07% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.06% |
| KNSA | Kiniksa Pharmaceuticals Ltd | Healthcare | Biotechnology | 2.03% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.03% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.01% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.98% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 1.98% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 1.97% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 1.95% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 1.94% |